Are biopsy specimens predictive of HER2 status in gastric cancer patients? - Wikidata - wikimedia - TriplyDB

Are biopsy specimens predictive of HER2 status in gastric cancer patients?

Are biopsy specimens predictive of HER2 status in gastric cancer patients?

http://www.wikidata.org/entity/Q44885327

about

HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach Comparison of HER2 and phospho-HER2 expression between biopsy and resected breast cancer specimens using a quantitative assessment method Tumor containing fragment number influences immunohistochemistry positive rate of HER2 in biopsy specimens of gastric cancer.Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type.Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens.Significant intratumoral heterogeneity of human epidermal growth factor receptor 2 status in gastric cancer: A comparative study of immunohistochemistry, FISH, and dual-color in situ hybridization.Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101).Rad51 expression is a useful predictive factor for the efficacy of neoadjuvant chemoradiotherapy in squamous cell carcinoma of the esophagus.RAS-expanded Mutations and HER2 Expression in Metastatic Colorectal Cancer: A New Step of Precision Medicine

P2860

Q26780318-211BAFB4-3520-451D-99B2-5CE02E161515 Q28535362-6F9AC394-8C66-47CE-8364-2A44F9E6EF0C Q33733858-FF9CDCFD-44A0-400B-8562-3F9687873D25 Q33779412-7108F7D2-A09C-4093-8BC8-CEBE1D41229D Q34852929-BDFBF894-CA84-46DC-827A-E0D3C7C8F21E Q36546068-DAB362D2-CED7-4778-9548-9066DA0F6CEF Q36801203-0986AB0F-CBD3-4C5C-9B33-C09498122C45 Q36999892-43377619-98F4-499A-8C57-82035DDB2504 Q37594158-DB6BAE6B-EF99-4EAF-856C-FE5CFA0A7DC0 Q57162471-60EC7BFE-3A6D-4F9D-83A9-FC898465489E

P2860

Are biopsy specimens predictive of HER2 status in gastric cancer patients?

http://www.wikidata.org/entity/Q44885327

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Are biopsy specimens predictive of HER2 status in gastric cancer patients?

@en

Are biopsy specimens predictive of HER2 status in gastric cancer patients?

@nl

type

label

Are biopsy specimens predictive of HER2 status in gastric cancer patients?

@en

Are biopsy specimens predictive of HER2 status in gastric cancer patients?

@nl

prefLabel

Are biopsy specimens predictive of HER2 status in gastric cancer patients?

@en

Are biopsy specimens predictive of HER2 status in gastric cancer patients?

@nl

P1433

Q44885327-3D4C11CF-3244-435D-AB2A-4B4330D8A54D

P1476

Q44885327-DB344DDD-81C6-4A82-9D51-B4076EF0B07C

P2093

Q44885327-06DDD375-9324-4D5C-B394-A4DDC2834EC7

Q44885327-1673701A-D169-4384-8904-C192C9DE70D5

Q44885327-6FC08F6A-9A98-4E47-9608-53AF9250EB3E

Q44885327-7A3F11A1-715C-4D8E-B8BE-A46883C6D36B

Q44885327-84DCF6E0-9D68-4D38-A76B-B1D118C9D81B

P2860

Q44885327-06593181-767D-4864-85FF-3769BA11B95C

Q44885327-0CCD4FB4-EC15-4E93-B1F7-970CDFDF6406

Q44885327-0D013210-EDC0-46C6-A506-60ECA792FE93

Q44885327-20F303AF-09A6-42E6-91B4-15C659DD58EE

Q44885327-232F5962-9D6B-41E7-B3AD-F05EAF1A226F

Q44885327-34681A88-CE62-44CA-A7D3-CE1A2A72FCAD

Q44885327-49055689-3472-4BD6-95C4-9AF3E756763B

Q44885327-589C015C-651B-4683-B4DA-B29B602A363B

Q44885327-5D916A6C-B44E-422D-BFBC-CCD3FE62B169

Q44885327-5DFB7A92-6311-403A-B7BF-EDC9A909AA0A

P2888

Q44885327-A6001E5A-0505-462F-98B4-5E937B426AF5

P304

Q44885327-5BD07A90-7C86-4664-B082-FC52A514F681

P31

Q44885327-82B47A15-08EB-4E50-8EAE-704547E7334E

P356

Q44885327-B3F06D57-C1ED-49AC-990F-3E8153A2AEA0

P433

Q44885327-DC2DE38A-258F-4844-911A-C07868D3ACB6

P478

Q44885327-90371464-9A1B-4D3F-BF54-540A7F6C1C39

P577

Q44885327-A13F0025-DF89-4165-A033-84DA83AB9E7F

P698

Q44885327-3DC6888B-04E6-4493-BED5-BB8C8A29E52F

P921

Q44885327-F8E822A1-330E-4BF9-8C6E-A582C1C029D0

P356

S10620-012-2357-3

P1433

Digestive Diseases and Sciences

P1476

Are biopsy specimens predictive of HER2 status in gastric cancer patients?

@en

P2093

A M Valentini

http://www.w3.org/2001/XMLSchema#string

M Di Maggio

http://www.w3.org/2001/XMLSchema#string

M L Caruso

http://www.w3.org/2001/XMLSchema#string

M Pirrelli

http://www.w3.org/2001/XMLSchema#string

R Armentano

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples.

Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma.

HER 2/neu protein expression in colorectal cancer

HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimens

TOPOIIalpha and HER-2/neu overexpression/amplification in Barrett's oesophagus, dysplasia and adenocarcinoma

Her-2/neu and breast cancer.

Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials.

P2888

s10620-012-2357-3

P304

397-404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10620-012-2357-3

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22918687

http://www.w3.org/2001/XMLSchema#string

P921